Cantitate/Preț
Produs

Clinical Trials of Drugs and Biopharmaceuticals

Editat de Chi-Jen Lee, Lucia H. Lee, Christopher L. Wu, Benjamin R. Lee, Mei-Ling Chen
en Limba Engleză Hardback – 19 sep 2005
The pharmaceutical industry is on the verge of an exciting and challenging century. Advances in pharmaceutical sciences have dramatically changed the processes of discovery and development of new therapeutic drugs and, in turn, resulted in an extraordinary increase in the potential prophylactic and therapeutic interventions. In this atmosphere, an intimate understanding of the mechanisms of pharmacokinetic and pharmacodynamic activity and the processes of drug evaluation is essential.Clinical Trials of Drugs and Biopharmaceuticals provides an overview of current procedures and major issues involved in drug and biopharmaceutical development. The book examines critical biochemical and pharmaceutical considerations for trials conducted during each phase of clinical development. It also reports information related to early pre-clinical evaluations of pharmacological activities and safety before proceeding with initiation of clinical trials. The sections focus on clinical assessments of drugs and biopharmaceuticals such as cardiovascular, respiratory, central nervous system, gastrointestinal and liver, genitourinary, skin, metabolism, and chemotherapeutic drugs as well as vaccines, biotechnology-derived therapeutics, and plant-based medicines.
Practical and informative, this step-by-step guide includes information on all four phases of clinical trials prior to licensure and covers the design of post-marketing studies. The editors examine how recent advances and increased demand for safer and more effective drugs have changed the process by which drugs are developed and approved.
Citește tot Restrânge

Preț: 141585 lei

Preț vechi: 190076 lei
-26% Nou

Puncte Express: 2124

Preț estimativ în valută:
27116 27937$ 22715£

Comandă specială

Livrare economică 01-15 februarie

Doresc să fiu notificat când acest titlu va fi disponibil:

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780849321856
ISBN-10: 0849321859
Pagini: 518
Ilustrații: 11 b/w images and 50 tables
Dimensiuni: 178 x 254 x 32 mm
Greutate: 1.09 kg
Ediția:Revised
Editura: CRC Press
Colecția CRC Press
Locul publicării:Boca Raton, United States

Public țintă

Professional

Cuprins

Preparation for Clinical Trials. Regulatory Organization and Decision Making. Evaluation and Quality Assurance of Drugs and Biopharmaceuticals. Future Perspectives in Drug Development

Recenzii

“This book is useful because it consolidates information from preclinical and clinical fields and also adds the perspective of regulatory agencies in bringing drugs to market…definitely is more ambitious than the previous edition.”
—Alan Poisner, M.D., Doody’s Book Review Service
“This volume provides an overview of current procedures and major issues involved in drug and biopharmaceutical development. The book examines critical biochemical and pharmaceutical considerations for trials conducted during each phase of clinical development. It also reports information related to early pre-clinical evaluations of pharmacological activities and safety before proceeding with the initiation of clinical trials. … Practical and informative, this step-by-step guide includes information on all four phases of clinical trials prior to licensure and covers the design of post-marketing studies. The editors examine how recent advances and increased demand for safer and more effective drugs have changed the process by which drugs are developed and approved.”
— In Anticancer Research, Vol. 26, 2006

Notă biografică

Chi-Jen Lee, Lucia H. Lee, Christopher L. Wu, Benjamin R. Lee, Mei-Ling Chen

Descriere

Based on the bestselling Handbook of Phase I/II Clinical Drug Trials, this newly named, completely revised and expanded volume details how recent advances and increasing demands for safety and efficacy have changed the process by which drugs are developed and approved. It examines critical considerations for trials conducted during each phase of clinical development. It also explores early pre-clinical evaluations of pharmacological activity and safety. Ten sections examining clinical assessment are organized according to anatomical targets (e.g. CNS, liver), functions (e.g. metabolic, chemotherapeutic) with another section covering vaccines, biotechnology-derived therapeutics, and plant-based medicines.